Inflamma­tory Brain Disorders
Conference 2027

Hosted by Neuroimmune Institute in partnership with Neuroimmune Foundation and accredited in collaboration with The Wisconsin Medical Society

May 20 – 21, 2027

A virtual CME event — 12.0 AMA PRA Category 1 Credits™
8:00 am – 4:30 pm PT each day

Registration now open to members. Become a member to enjoy exclusive benefits.
Neuroimmune Institute (Logo)
Neuroimmune Foundation logo of a tree with magenta berries.

Join us for a two day virtual conference live via Zoom.

Based on feedback from prior conferences, the 2027 conference will continue to be more clinically focused while still highlighting research advances.

The Inflammatory Brain Disorders Conference features nationally and internationally renowned experts skilled in diagnostic and therapeutic approaches who will present a diverse range of emerging clinical and research challenges, insights, and advances in the field of inflammatory brain disorders. Presentations are carefully selected to familiarize attendees with rapidly developing research and to educate clinicians on the latest understanding of treatment options.

Both generalists as well as specialists in pediatric and adult medicine will find the conference valuable to their practices. The intended audience is pediatricians, family physicians, psychiatrists, rheumatologists, immunologists, neurologists, and infectious disease physicians. Though the conference is designed for physicians, all are welcome to attend.

Physician comments from our prior conferences can be found below. Greater than 90% of physicians in attendance rated the overall quality of the 2021, 2022, 2023, 2024, 2025, and 2026 conferences as 5/5.

No refunds will be granted for any reason. While this meeting is geared towards physicians and researchers; parents, patients, and community members are welcome to attend the virtual conference.

Sponsorship opportunities are available! Please email conference@neuroimmuneinstitute.org for details.

Thank you to our Stanford, UCSF and USYD collaborators and hosts/moderators, Dr. Larry Steinman, Dr. Sam Pleasure, and Dr. Russell Dale.

Stanford University

Stanford University

UCSF Weill Institute for Neurosciences

UCSF Weill Institute for Neurosciences

University of Sydney, Anderson-Stuart-Building

University of Sydney

2027 Conference Agenda

Please find all information on speaker biographies, presentation summaries, and disclosure information in the conference agenda.

The full agenda will be available in Spring 2027.

2027 Moderators/Hosts

Anna Conkey

Anna Conkey

Executive Director and Founder, Neuroimmune Institute and Neuroimmune Foundation

Doctor Lawrence Steinman.

Lawrence Steinman, MD

Professor of Neurology and Pediatrics, Stanford University School of Medicine

Doctor Samuel Pleasure.

Sam Pleasure, MD, PhD

Professor, Department of Neurology, UCSF; Co-Director, Center for Encephalitis and Meningitis, UCSF

Professor Russell Dale

Russell Dale, MBChB, MRCP, PhD

Professor of Paediatric Neurology and Paediatric Neurology Research, University of Sydney

Confirmed 2027 Speakers

Professor Ed Bullmore

Ed Bullmore, FRCPsych, FRCP, FMedSci, FRS

Regius Professor of Psychiatry, King’s College London; Head, School of Academic Psychiatry, Institute of Psychiatry, Psychology & Neuroscience; Emeritus Professor of Psychiatry, University of Cambridge; Honorary Fellow, Downing College, Cambridge

Brain Health and the Immune System
Professor Michael Berk

Michael Berk, AO, MBBCh, PhD, FRANZCP

Deakin Distinguished Professor of Psychiatry, NHMRC Leadership Level 3 Research Fellow, School of Medicine, Deakin University and Barwon Health; Scientific Director, Deakin Institutes for Health and IMPACT – the Institute for Mental and Physical Health and Clinical Translation

Drug Repurposing in Psychiatry: Emerging Therapeutic Opportunities
Professor Rachel Upthegrove

Rachel Upthegrove, MBE, MBBS, MPhil, PhD, FRCPsych

Professor of Psychiatry, Department of Psychiatry, University of Oxford; Director, Oxford Health Biomedical Research Centre; Chair, NIHR Mental Health Translational Research Collaboration; NIHR Senior Investigator

Immuno-Metabolic Dysfunction in Early Stages of Severe Mental Illness: Evidence From Cells to Large-Scale Electronic Records
Cameron Carter, MD

Cameron Carter, MD

Distinguished Professor and Chair, Department of Psychiatry and Human Behavior, University of California, Irvine School of Medicine; Editor-in-Chief, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

Neuroimmune Mechanisms in Psychosis

John C. Probasco, MD

Professor of Neurology, Johns Hopkins University School of Medicine; Vice Chair for Quality, Safety, and Service, Department of Neurology; Director, Division of Advanced Clinical Neurology; Medical Director, Inpatient General Neurology Service, Johns Hopkins Hospital

Diagnosis and Treatment of Autoimmune Encephalitis
Geraldina Lionetti, MD

Geraldina Lionetti, MD

Professor of Pediatric Rheumatology, University of California, San Francisco (UCSF); Medical Director and Section Chief, Pediatric Rheumatology Program, UCSF Benioff Children’s Hospital Oakland

Exploring the Role of Biologic and Targeted Synthetic DMARDs in Rheumatology and Inflammatory Brain Disease
Doctor Sarosh Irani.

Sarosh Irani, BMBCh MA (Oxon), DPhil

Professor of Neurology, Professor of Neuroscience, Consultant Neurologist, Departments of Neurology and Neurosciences, Mayo Clinic, Florida

The Comparative Features, Biology and Treatments Across Autoimmune Encephalitis Syndromes
Partinen Markku, MD

Markku Partinen, MD, PhD, FAAN

Professor and Principal Investigator, Department of Clinical Neurosciences, Clinicum, University of Helsinki, Finland; Neurologist and Senior Consultant in Sleep Medicine

Sleep, Autonomic Dysfunction, and PANS/PANDAS
Professor Russell Dale

Russell Dale, MBChB, MRCP, PhD

Professor of Paediatric Neurology and Paediatric Neurology Research, University of Sydney

Therapeutic Decision Making in PANS and Autistic Regression: Principles and Feasibility
Amanda Piquet, MD

Amanda Piquet, MD

Professor, Department of Neurology, University of Colorado Anschutz Medical Campus; Director, Autoimmune Neurology Program; Céline Dion Foundation Endowed Chair in Autoimmune Neurology; Associate Program Director, NeuroID & Autoimmune Neurology Fellowship

CAR T Cell Therapy in Autoimmune Neurology
Hal Hoffman, MD

Hal Hoffman, MD

Professor of Pediatrics and Medicine, University of California San Diego; Chief, Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, UC San Diego and Rady Children’s Hospital–San Diego; Director, Hoffman Laboratory

Inflammasome-Mediated Neuroinflammation
Jarred Younger, PhD

Jared Younger, PhD

Professor, Department of Psychology, University of Alabama at Birmingham (UAB); Director, Neuroinflammation, Pain, and Fatigue Laboratory

Pinpointing the Source of Brain Inflammation in ME/CFS
Dr. Janet Cunningham

Janet Cunningham, MD, PhD

Professor at Department of Medical Sciences, Clinical Psychiatry, Uppsala University, Sweden; Consultant Psychiatrist, Uppsala University Hospital

International Consensus for CSF Testing in Psychiatric Disorders, Established and Emerging Markers
Doctor Jennifer Frankovich.

Jennifer Frankovich, MD

Clinical Professor of Pediatrics, Division of Rheumatology, Stanford University School of Medicine; Director, Stanford PANS Research Program

Recognizing Inflammatory Signs in Patients With PANS and Beyond: Which Labs to Order and How to Interpret
Dr. David Putrino

David Putrino, PhD

Professor of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai; Director of Rehabilitation Innovation, Mount Sinai Health

Lumbrokinase in Long COVID, ME/CFS, and Post-Treatment Lyme Disease Syndrome: Results of an Open-Label Trial
Svetlana Blitshteyn, MD

Svetlana Blitshteyn, MD, FAAN, FANA

Clinical Associate Professor of Neurology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences; Director/Founder, Dysautonomia Clinic

Dysautonomia, ME/CFS, and Long COVID as Neuroimmune Disorders
Erin Stolte, MD

Erin Stolte, MD

Assistant Clinical Professor, Department of Psychiatry in the Faculty of Medicine & Dentistry, University of Alberta

Autoimmune Psychiatry, Case Presentation and the Value of Persistence With Immunotherapy

Learning and Outcome Objectives

  • Learn how to accurately diagnose and effectively treat inflammatory brain conditions.
  • Recognize that neuropsychiatric sequelae can result from infections, autoimmune, and inflammatory conditions.
  • List several immune and inflammatory markers that can be present in patients with inflammatory brain disorders.
  • Report the cognitive and psychiatric effects that can occur post-infection.
  • Describe appropriate treatments for patients with inflammatory brain disorders.

Accreditation / Credit Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Wisconsin Medical Society and Neuroimmune Institute. The Wisconsin Medical Society is accredited by the ACCME to provide continuing medical education for physicians.

The Wisconsin Medical Society designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accommodations

Neuroimmune Institute subscribes to the articles of Title III of the Americans with Disabilities Act of 1990. Should you or anyone accompanying you require special assistance, please notify us by contacting conference@neuroimmuneinstitute.org. Requests should be made as early as possible to allow time to arrange the accommodation.

Comments from Prior Inflammatory Brain Disorders Conferences

The Inflammatory Brain Disorders Conference was (again) the most educational and effective conference I have ever attended in my 43 years as a physician! International experts presented 16 lectures over the course of two days, delivering major gems every hour to facilitate the diagnosis and treatment of tough psychiatric and neurologic neuroinflammatory conditions. A cumulative tsunami paradigm shift for psychiatry is in the works; inflammatory brain disorders will be the rule, rather than the exception. My accolades to all the panel of experts who shared their latest research and efforts. Thank you!

Martin T. Jensen, MD
Adult, Adolescent, & Child Psychiatry, Laguna Niguel, CA

Wonderful conference! First time I attended this conference. Neuroinflammatory diseases are not a large part of my practice as a pediatric rheumatologist – at least I thought so before the conference. Given the expanding scope of diseases related to neuroinflammation, my preconceived notions have been challenged – in a good way! Each presentation was given by an obvious thought leader and the results presented were all cutting edge. Cannot wait until next year.

Daniel Lovell, MD, MPH
Pediatric Rheumatologist, Cincinnati, OH

Rigorous, wide-ranging, two-day conference by international faculty providing cutting edge genetic and clinical insights furthering the rapidly increasing knowledge about auto-immune mediated syndromes. Crisp presentations, excellent slides, and clinical movie clips combined with meticulous attention to the duration of the presentations. Information was presented on the autoimmune manifestations of Long Covid-19, PANS, PANDAS, postural orthostatic tachycardia syndrome (POTS), psychoses, seizure disorders and tick-borne illnesses alongside presentations on the Gut Microbiome and porosity of the blood brain barrier. Commercial-free. Well worth the tuition. My first Inflammatory Brain Disorders Conference. Planning on next year.

John Esterhai, MD
Orthopedic Surgeon, Spring House, PA

When I go to a conference, I feel that I have gotten my money’s worth if at least 10% of what I learn is new. In this course, the new information was at least 60% and what I did know was expanded significantly. This has increased my understanding and sensitivity to the possibility of an immune disorder in patients I have seen over the years. There are several patients in my current practice who will be re-evaluated for the possibility of something I did not know to look for before.

Lee Solomon, MD
Psychiatry, Chattanooga, TN

This was a conference with fantastic collaborators and speakers. As a physician I felt that it was clinically oriented and cutting edge. It was incredibly useful to gain knowledge in a field like neuroimmunology where so little is known.

Anuja Vyas, MD, FACOG
Texas

This is the most comprehensive, well-organized, and current information on all topics I have encountered in such a long time. I plan to attend every conference moving forward. Thank you for such well-presented information. Armed with several screenshots of slides, I have already contacted several patients to complete a more thorough history for a more complete treatment plan. So grateful.

Maria Del Sol, MD
Child and Adolescent Psychiatrist, Florida

As a clinical psychiatrist, it is crucial that I understand the potential origins of psychiatric symptoms. This conference gave insight into infectious and immune mechanisms for Neuropsychiatric symptoms that I found truly valuable. The speakers were of top quality.

Matthew Bernstein, MD
Psychiatrist, Massachusetts

I was astounded by the amount of scientifically based data presented on encephalopathy, COVID and PANS/PANDAS at this conference. I thought all of the presenters at this conference did an excellent job explaining the pathophysiology involved in the various conditions that were highlighted in this conference.

Urszula Kotlow, MD
Pediatric Psychiatrist, CPAE Clinic, Banner Desert Medical Center, Arizona

I feel more confident as THE consultant on many of these cases due to expanded knowledge I have acquired via this resource. Excellent presentations with fantastic evidence-based information. I hope to be involved in more conferences. Thanks to all!

Sandra Lawrence, MD, FACR
Pediatric Rheumatology, Florida

The neuroimmune conference transformed my thinking about the relationship between infection, neurobiology and psychiatric disorders. I learned so much.

Melissa Aguirre, MD
Pediatrician, California

This conference had the highest scientific quality and rigor, and all the presenters and discussants were outstanding. The contribution of the foundation for children with neuroimmune disorders to society is incommensurable.

Rosa Aurora Chavez, MD, PhD, FABP
Washington, DC

2027 Registration and Payment – Virtual CME Event

Currently open only to members.

Members enjoy reduced 2027 conference admission rates. Become a member and receive exclusive benefits.
  • An optional add-on for recording access is available for $100 but can only be purchased at the time of event registration (no exceptions). CME credit is solely available to attendees of the live virtual event. (For instance, if you watch the recording, we are not authorized to provide CME credit).
  • Registration includes access via one device only. You may switch devices during the event, but must sign out from one device before resuming viewing via another device.
  • Your registrations links will arrive directly from Zoom one week, one day, and one hour before the conference.
  • There are no refunds for any reason.
  • Full price (live virtual attendance without recordings) for the conference is $899 so we encourage you to register early or become a Clinician Member or an Impact Circle Member to enjoy reduced rates.
Join us!

CME Evaluation

Individuals wishing to claim CME credit must attend the live event (virtually) and fill out their CME evaluation no later than May 24, 2027. Please note that your CME certificates will arrive in your email within couple hours of submission. Please be sure to check your spam if you do not see it. Please email us no later than May 24, 2027 if you have not received a copy of your CME certificate.

Sponsors

Logos for UW Health, Unity Point Health Meriter, and Quartz.

If you are interested in sponsoring an educational grant, please email us at conference@neuroimmuneinstitute.org.